This study is currently recruiting.
Description: The behavioral issues associated with a Fragile X diagnosis can create daily challenges for your child. Learn more about a clinical trial evaluating investigational topical cannabidiol (CBD) gel to see if it helps improve Fragile X-related behavioral issues.
Eligibility & Criteria
IRB #:00281916
Principal Investigator: Dejan B. Budimirovic, MD
Eligible Age Range: Children between the ages of 3 and 17
Gender: All
Diagnosis: Diagnosed via genetic testing, with Fragile X syndrome
Contact Information: Call the Clinical Trials Unit at Kennedy Krieger Institute at 443-923-3850.